Announcing a new publication for Acta Materia Medica journal. Neurologic disorders are the leading cause of illness and disability as a result of increased life expectancy and global population aging, highlighting the urgent need and great challenge for discovering neuroprotective agents with better efficacy and minimal side-effects.
Catalpol, an iridoid glycoside derived from Rehmanniae Radix, has therapeutic potential in neurologic diseases due to its diverse biological activities. This review summarizes the research advances and therapeutic potential of catalpol for a wide range of neurologic disorders, including depression, cognitive impairment, stroke, Parkinson’s disease, and multiple sclerosis.
A comprehensive discussion of experimental models…